“Global Duodenoscopes Market to reach a market value of USD 2.29 Billion by 2032 growing at a CAGR of 5.1%”
The Global Duodenoscopes Market size is expected to reach $2.29 billion by 2032, rising at a market growth of 5.1% CAGR during the forecast period.
The United States, in particular, has a well-established network of hospitals and endoscopy centers and favorable reimbursement policies that support using duodenoscopes in diagnostic and therapeutic procedures. Furthermore, strong regulatory oversight and continuous efforts to enhance patient safety have spurred demand for reusable and disposable duodenoscope models across the region. Thus, the North America segment recorded 44% revenue share in the market in 2024. This dominance can be attributed to the region’s advanced healthcare infrastructure, high adoption rate of innovative medical technologies, and the increasing prevalence of gastrointestinal disorders.
Minimally invasive endoscopic procedures have become the standard in modern healthcare, driving the demand for duodenoscopes. These procedures offer many advantages over traditional surgical approaches, including reduced recovery times, minimal scarring, and a lower risk of complications. Duodenoscopes, which are essential for procedures such as endoscopic retrograde cholangiopancreatography (ERCP), play a critical role in enabling physicians to access and treat the duodenum, bile ducts, and pancreas without the need for large incisions. In conclusion, the growing preference for minimally invasive endoscopic procedures drives the market's growth.
Additionally, the expansion of healthcare infrastructure is a pivotal driver of the market. As healthcare systems worldwide continue to grow and evolve, more hospitals, clinics, and specialized healthcare centers are equipped with advanced endoscopic tools, including duodenoscopes. In both developed and emerging economies, governments and private sectors are investing heavily in upgrading healthcare facilities, increasing their capacity to deliver high-quality endoscopic services. Expanded access to modern medical technologies enables more healthcare professionals to incorporate duodenoscopes into their diagnostic and therapeutic practices. Thus, as healthcare systems continue to evolve and expand, the demand for duodenoscopes will inevitably grow, contributing to global market expansion.
The COVID-19 pandemic significantly disrupted the market. As hospitals and healthcare facilities shifted their focus toward managing the overwhelming number of COVID-19 cases, elective procedures, including many endoscopic examinations, were postponed or cancelled. This led to a sharp decline in the demand for duodenoscopes, which are primarily used in gastrointestinal diagnostic and therapeutic procedures. Thus, the COVID-19 pandemic had a negative impact on the market.
However, one of the key restraints limiting the growth of the market is the high cost and logistical challenges associated with single-use duodenoscopes. While single-use duodenoscopes have been introduced to reduce the risk of cross-contamination and infection, they come with a significant price tag. The cost per unit of a single-use duodenoscope is considerably higher than reusable models, making it a more expensive option for hospitals and healthcare systems, particularly in cost-sensitive regions. For many healthcare providers, especially those in emerging markets or smaller healthcare facilities, the high expense of single-use duodenoscopes poses a financial burden that could lead to reduced adoption. Therefore, this economic barrier could hinder the adoption of single-use duodenoscopes, impacting the overall growth of the duodenoscope market in certain regions.
The leading players in the market are competing with diverse innovative offerings to remain competitive in the market. The above illustration shows the percentage of revenue shared by some of the leading companies in the market. The leading players of the market are adopting various strategies in order to cater demand coming from the different industries. The key developmental strategies in the market are Acquisitions, and Partnerships & Collaborations.
On the basis of application, the market is classified into diagnostics and therapeutics/ treatment. The therapeutics/ treatment segment recorded 68% revenue share in the market in 2024. These instruments are vital in various therapeutic interventions, including bile duct stent placements, stone extractions, and sphincterotomies. As endoscopic procedures continue to evolve, the use of duodenoscopes in therapeutic applications has expanded, especially in managing complex pancreatic and biliary diseases.
By end use, the market is divided into hospitals and outpatient facilities. The outpatient facilities segment garnered 53% revenue share in the market in 2024. These centers are increasingly preferred for less invasive and routine endoscopic procedures due to their cost-effectiveness, shorter wait times, and quicker patient turnaround. Advances in duodenoscope technology and the growing trend of shifting procedures from inpatient to outpatient settings have made it feasible for these facilities to offer high-quality care.
Based on product, the market is characterized into reusable and disposable. The disposable segment procured 15% revenue share in the market in 2024. The demand for disposable duodenoscopes has risen as healthcare institutions focus more on infection control and reducing cross-contamination risks. Single-use devices eliminate the need for complex reprocessing and minimize the chances of patient-to-patient transmission of pathogens.
The reusable segment is further subdivided into flexile and rigid. The rigid segment held 9% revenue share in the market in 2024. Although less commonly used than flexible scopes, rigid duodenoscopes remain relevant in specific clinical scenarios where straight access is sufficient, and flexibility is not a primary requirement. These scopes are known for their structural stability and durability, which can be beneficial in certain diagnostic procedures.
Free Valuable Insights: Global Duodenoscopes Market size to reach USD 2.29 Billion by 2032
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Europe segment witnessed 30% revenue share in the market in 2024. The region benefits from a growing elderly population, rising incidence of digestive disorders, and increasing investment in endoscopic technologies. European countries emphasize minimally invasive diagnostic and treatment techniques, which support using duodenoscopes across healthcare settings.
| Report Attribute | Details |
|---|---|
| Market size value in 2024 | USD 1.56 Billion |
| Market size forecast in 2032 | USD 2.29 Billion |
| Base Year | 2024 |
| Historical Period | 2021 to 2023 |
| Forecast Period | 2025 to 2032 |
| Revenue Growth Rate | CAGR of 5.1% from 2025 to 2032 |
| Number of Pages | 244 |
| Number of Tables | 400 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Market Share Analysis, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives |
| Segments covered | Product, Application, End Use, Region |
| Country scope |
|
| Companies Included | Olympus Corporation, Ambu A/S, Boston Scientific Corporation, Fujifilm Holdings Corporation, SonoScape Medical Corp., Karl Storz SE & Co. KG, Hoya Corporation, Medtronic PLC, EndoMed Systems GmbH, Smart Medical Systems Ltd. |
By Application
By Product
By End Use
By Geography
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 